Free press releases distribution network?

More news: Health/Surgery
Agency / Source: General Electric Company

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



GE Healthcare and Neste Jacobs Form Strategic Alliance to Drive Worldwide Self-sufficiency in Blood Plasma Fractionation - GE Healthcare, the healthcare business of GE and Neste Jacobs Oy, announced that the companies have formed a strategic alliance to assist countries worldwide to become self-sufficient in the manufacture of blood plasma products - NesteJacobs.com
GE Healthcare and Neste Jacobs Form Strategic Alliance to Drive Worldwide Self-sufficiency in Blood Plasma Fractionation

 

PRZOOM - /newswire/ - Chalfont St Giles, United Kingdom, 2011/11/21 - GE Healthcare, the healthcare business of GE and Neste Jacobs Oy, announced that the companies have formed a strategic alliance to assist countries worldwide to become self-sufficient in the manufacture of blood plasma products - NesteJacobs.com. NYSE: GE

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• Companies to help countries develop their own manufacturing capabilities for blood plasma products, reducing reliance on imports;
• Alliance will help healthcare providers worldwide increase access to life-saving treatments.

GE Healthcare, the healthcare business of GE and Neste Jacobs Oy, a leading global expert in plasma fractionation plant engineering design and construction, announced today that the companies have formed a strategic alliance to assist countries worldwide to become self-sufficient in the manufacture of blood plasma products. The alliance will combine GE Healthcare’s expertise in bioprocessing for plasma fractionation with Neste Jacobs’s global bio-engineering and construction capabilities. Together, the companies will offer governments and pharmaceutical companies an integrated, cost-competitive “turn-key” approach for the construction of plasma fractionation plants, to help meet the rising worldwide demand for these potentially life-saving treatments. The alliance between the two companies aligns with GE’s healthymagination initiative, which focuses on reducing cost, increasing access and improving quality in healthcare.

Human blood plasma, the liquid component of blood, is the source of many proteins such as Factor VIII, Factor IX, Immunoglobulin and Albumin. These protein products, which are prepared from plasma via a process known as fractionation, are used to treat a wide variety of serious and often life-threatening conditions such as shock, trauma, infections, immunological disorders, Hemophilia A and B, and other blood disorders. The global demand for blood plasma products is predicted to grow from $13 billion in 2009 to an estimated $26.5 billion by 2015*. However healthcare providers in many countries, especially emerging nations, are unable to meet demand for these treatments. The World Federation of Hemophilia estimates that globally 400,000 people are living with hemophilia, of whom only 25% receive adequate treatment. Helping countries to become self-sufficient in the fractionation of locally collected plasma will overcome many of these unmet healthcare needs.

Olivier Loeillot, General Manager of Enterprise Solutions, GE Healthcare Life Sciences said “GE Healthcare is known as a leading provider of technologies for plasma fractionation. The alliance with Neste Jacobs means we can combine our expertise and our extensive process equipment, consumables and project management services with the world-class capabilities of one of the foremost engineering companies in this field. By working together to bring an integrated offering – from financing and construction of the plant, right through to training of the operational staff - we can make it much easier for governments and other healthcare providers to acquire these essential capabilities. This is a big step forward in bringing simple yet vital healthcare to people who, up to now, have been denied these treatments.”

Jarmo Suominen, the Managing Director and CEO of Neste Jacobs said “Neste Jacobs has over 30 years’ experience in the design of plasma fractionation plants, all over the world, and we’re delighted to form this alliance with GE Healthcare. We have a shared vision of bringing an integrated approach to plasma fractionation, to drive efficiency and simplicity in the construction of new plants. Combining the unique competences and know-how of our respective companies will help secure the delivery of turn-key solutions to the plasma products industry including construction of complete green field facilities. This alliance gives us an excellent opportunity to better serve clients investing in plasma fractionation world-wide."

* BCC Research,“The Blood Industry” Market Research Report, 2011

About GE Healthcare
GE Healthcare (gehealthcare.com) provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.

For more detailed information on GE Healthcare’s products for biopharmaceutical manufacture and plasma fractionation visit gelifesciences.com

For our latest news, please visit newsroom.gehealthcare.com/.

About Neste Jacobs
Neste Jacobs (nestejacobs.com) is a preferred solution provider of high-quality technology, engineering, and project services for a wide range of industries in the chemicals and biotechnology fields. We have more than 50 years of experience in technology development and industrial investment projects in Europe, North America, Asia and the Middle East, and are looking to grow in the expanding markets in particular. Neste Jacobs’ specific plasma fractionation experience reaches back to late 1970's, since then we have continuously provided successful plasma fractionation solutions to our customers.

Media Contact:
Neste Jacobs - Jarmo Suominen, MD & CEO
T +358 50 458 3399 / E: jarmo.suominen[.]nestejacobs.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: General Electric Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


GE Healthcare and Neste Jacobs Form Strategic Alliance to Drive Worldwide Self-sufficiency in Blood Plasma Fractionation

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
GE News Center | Neste Jacobs
Contact: Dr Val Jones - GE Healthcare 
+44(0)14 9449 8052 val.jones[.]ge.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any General Electric Company securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From General Electric Company / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Ultimate Medical Group Announces A New Regenerative Medicine Division

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  Triggr & Bloom

Visit  BizJobs.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today